AngioDynamics to Host Virtual Cardiovascular Investor Event
AngioDynamics (NASDAQ: ANGO), a medical technology company specializing in vascular health and cancer treatment, has announced a virtual cardiovascular investor event scheduled for Wednesday, April 2, 2025.
The event will commence at 9:00 AM ET, immediately following the company's Fiscal 2025 Third Quarter Financial Results Conference Call at 8:00 AM ET. During this 60-minute session, AngioDynamics will provide an in-depth exploration of their cardiovascular technology portfolio and strategic vision.
Investors can access the webcast through the company's website at www.angiodynamics.com under the 'Investors' section or via the provided registration link.
AngioDynamics (NASDAQ: ANGO), un'azienda di tecnologia medica specializzata nella salute vascolare e nel trattamento del cancro, ha annunciato un evento virtuale per investitori nel settore cardiovascolare programmato per mercoledì 2 aprile 2025.
L'evento avrà inizio alle 9:00 AM ET, subito dopo la conferenza telefonica sui risultati finanziari del terzo trimestre dell'anno fiscale 2025, che si terrà alle 8:00 AM ET. Durante questa sessione di 60 minuti, AngioDynamics fornirà un'esplorazione approfondita del proprio portafoglio tecnologico cardiovascolare e della visione strategica.
Gli investitori possono accedere al webcast attraverso il sito web dell'azienda all'indirizzo www.angiodynamics.com nella sezione 'Investitori' o tramite il link di registrazione fornito.
AngioDynamics (NASDAQ: ANGO), una empresa de tecnología médica especializada en salud vascular y tratamiento del cáncer, ha anunciado un evento virtual para inversores en el sector cardiovascular programado para miércoles 2 de abril de 2025.
El evento comenzará a las 9:00 AM ET, inmediatamente después de la conferencia telefónica sobre los resultados financieros del tercer trimestre del año fiscal 2025, que se llevará a cabo a las 8:00 AM ET. Durante esta sesión de 60 minutos, AngioDynamics ofrecerá una exploración profunda de su cartera de tecnología cardiovascular y su visión estratégica.
Los inversores pueden acceder al webcast a través del sitio web de la empresa en www.angiodynamics.com en la sección 'Inversores' o mediante el enlace de registro proporcionado.
AngioDynamics (NASDAQ: ANGO), 혈관 건강 및 암 치료를 전문으로 하는 의료 기술 회사가 2025년 4월 2일 수요일로 예정된 가상 심혈관 투자자 이벤트를 발표했습니다.
이 행사는 오전 9시 ET에 시작되며, 오전 8시 ET에 진행되는 회사의 2025 회계연도 3분기 재무 실적 컨퍼런스 콜 직후에 진행됩니다. 60분 동안 진행되는 이 세션에서 AngioDynamics는 심혈관 기술 포트폴리오와 전략적 비전에 대한 심도 있는 탐구를 제공합니다.
투자자는 회사 웹사이트 www.angiodynamics.com의 '투자자' 섹션 또는 제공된 등록 링크를 통해 웹캐스트에 접근할 수 있습니다.
AngioDynamics (NASDAQ: ANGO), une entreprise de technologie médicale spécialisée dans la santé vasculaire et le traitement du cancer, a annoncé un événement virtuel pour les investisseurs dans le domaine cardiovasculaire prévu pour mercredi 2 avril 2025.
L'événement commencera à 9h00 ET, immédiatement après la conférence téléphonique sur les résultats financiers du troisième trimestre de l'exercice 2025, qui se tiendra à 8h00 ET. Au cours de cette session de 60 minutes, AngioDynamics présentera une exploration approfondie de son portefeuille technologique cardiovasculaire et de sa vision stratégique.
Les investisseurs peuvent accéder au webinaire via le site web de l'entreprise à l'adresse www.angiodynamics.com dans la section 'Investisseurs' ou via le lien d'inscription fourni.
AngioDynamics (NASDAQ: ANGO), ein Medizintechnikunternehmen, das sich auf vaskuläre Gesundheit und Krebsbehandlung spezialisiert hat, hat eine virtuelle Investorenveranstaltung im Bereich der Kardiovaskulären Medizin für Mittwoch, den 2. April 2025 angekündigt.
Die Veranstaltung beginnt um 9:00 Uhr ET, unmittelbar nach der Telefonkonferenz zu den Finanzzahlen des dritten Quartals des Geschäftsjahres 2025, die um 8:00 Uhr ET stattfindet. Während dieser 60-minütigen Sitzung wird AngioDynamics eine eingehende Erkundung seines Portfolios an kardiovaskulären Technologien und seiner strategischen Vision bieten.
Investoren können über die Unternehmenswebsite www.angiodynamics.com im Bereich 'Investoren' oder über den bereitgestellten Registrierungslink auf das Webcast zugreifen.
- None.
- None.
Virtual Cardiovascular Investor Event
Date: Wednesday, April 2, 2025
Time: 9:00am ET
Duration: 60 minutes
Webcast Registration Link: https://viavid.webcasts.com/starthere.jsp?ei=1712212&tp_key=cedf6b19b1
Event Overview
AngioDynamics will provide investors a deeper dive into the cardiovascular technology portfolio and strategic vision.
The event will be webcast and can be accessed through the "Investors" section of the AngioDynamics website at www.angiodynamics.com.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250331827841/en/
Investors:
AngioDynamics, Inc.
Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408
strowbridge@angiodynamics.com
Media:
Saleem Cheeks
Vice President, Communications
518-795-1174
scheeks@angiodynamics.com
Source: AngioDynamics, Inc.
FAQ
When is AngioDynamics (ANGO) hosting its virtual cardiovascular investor event in 2025?
How long will the ANGO cardiovascular investor event last?
What will be discussed at AngioDynamics' (ANGO) April 2025 investor event?
How can investors access the ANGO cardiovascular investor event in April 2025?
What time is ANGO's Q3 FY2025 earnings call before the cardiovascular event?
